Decitabine in Treating Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Recurrent Bladder Cancer|Recurrent Breast Cancer|Recurrent Melanoma|Stage III Melanoma|Stage IV Bladder Cancer|Stage IV Breast Cancer|Stage IV Melanoma|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: DRUG: decitabine|OTHER: pharmacological study|OTHER: laboratory biomarker analysis
Sponsor: National Cancer Institute (NCI)